Article PDF
References
Watson WA, Litovitz TL, Rodgers GC, Klein-Schwartz W, Reid N, Youniss J, et al. 2004 annual report of the American association of poison control centers toxic exposure surveillance system. Am J Emerg Med2005; 23: 589–666.
Litovitz TL, Klein-Schwartz W, Dyer KS, Shannon M, Lee S, Powers M. 1997 annual report of the American Association of Poison Control Centers toxic exposure surveillance system. Am J Emerg Med1998; 16: 443–497.
Osterhoudt KC. Principles of epidemiology and research design. In: Goldfrank LR, Flomenbaum NE, Lewin NA, Howland MA, Hoffman RS, Nelson LS, editors. Goldfrank’s Toxicologic Emergencies (7th ed.). New York: McGraw Hill;2002. pp 1789–1797.
Osterhoudt KC. Toxic topic: This treat is not so sweet: exploratory sulfonylurea ingestion by a toddler. Pediatr Case Reviews2003; 4: 215–217.
Little GL, Boniface KS. Are one or two dangerous? Sulfonylurea exposure in toddlers. J Emerg Med2005; 28: 305–310.
Osterhoudt KC. The toxic toddler: drugs that can kill in small doses. Contemp Pediatr2000; 17: 73–88.
Bar-Oz B, Levichek Z, Koren G. Medications that can be fatal for a toddler with one tablet or teaspoonful: a 2004 update. Paediatric Drugs2004; 6:123–6.
Michael JB, Sztajnkrycer MD. Deadly pediatric poisons: nine common agents that kill at low doses. Emerg Med Clin NA2004; 22: 1019–1050.
Sketris L, Wheeler D, York S. Hypoglycemic coma induced by inadvertent administration of glyburide. Drug Intell Clin Pharm1984; 18: 142–143.
Quadrani DA, Spiller HA, Widder P. Five-year retrospective evaluation of sulfonylurea ingestion in children. J Toxicol Clin Toxicol1996; 34: 267–270.
Borowski H, Caraccio T, Mofensen H. Sulfonylurea ingestion in children: is an 8-hour observation period sufficient? J Pediatr1998; 133: 584.
Szlatenyi CS, Capes KF, Wang RY. Delayed hypoglycemia in a child after ingestion of a single glipizide tablet. Ann Emerg Med1998; 31: 773–776.
Greenberg B, Weihl C, Hug G. Chlorpropamide poisoning. Pediatrics1968; 41: 145–147.
Palatnick W, Meatheral RC, Tenenbein M. Clinical spectrum of sulfonylurea overdose and experience with diazoxide therapy. Arch Intern Med1991; 151: 1859–1862.
Spiller HA, Villalobos D, Krenzolak EP, Anderson BD, Gorman SE, Rose SR, et al. Prospective multi-center study of sulfonylurea ingestion in children. J Pediatr1997; 131: 141–146.
Robertson WO. Sulfonylurea ingestions: hospitalization not mandatory. J Toxicol Clin Toxicol1997; 35: 115–116.
Robertson WO. Delayed hypoglycemia after ingestion of a single glipizide tablet [letter, comment]. Ann Emerg Med1999; 33: 130.
Burkhart KK. When does hypoglycemia develop after sulfonylurea ingestion? Ann Emerg Med1998; 31: 771–772.
Spiller HA. Management of sulfonylurea ingestions. Pediatr Emerg Care1999; 15: 227–230.
Thomas DK. Hypoglycemia in children before operation: its incidence and prevention. Br J Anesth1974; 46:66–68.
Marin G, Rose SR, Kibarian M, Barnes K, Cassorla F. Absence of dawn phenomenon in normal children and adolescents. Diabetes Care1988; 11:393–396.
Graudins A, Linden CH, Ferm RP. Diagnosis and treatment of sulfonylurea-induced hyperinsulinemic hypoglycemia. Am J Emerg Med1997; 15: 95–96.
Ingels M. Hypoglycemic agents and insulin. In: Erickson TB, Ahrens WR, Aks SE, Baum CR, Ling LJ, editors. Pediatric Toxicology. New York: McGraw Hill;2005. pp 277–282.
Boyle PJ, Justice K, Krentz AJ, Nagy RJ, Schade DS. Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses. J Clin Endocrinol Metab1993; 76: 752–756.
McLaughlin SA, Crandall CS, McKinney PE. Octreotide: an antidote for sulfonylurea-induced hypoglycemia. Ann Emerg Med2000; 36: 133–138.
Carr R, Zed PJ. Octreotide for sulfonylurea-induced hypoglycemia following overdose. Annals Pharmacother2002; 36: 1727–1732.
Glaser B, Hirsch HJ, Landau H. Persistent hyperinsulinemic hypoglycemia of infancy: long-term octreotide treatment without pancreatectomy. J Pediatr.1993 Oct;123(4):644–50.
Radetti G, Gentili L, Paganini C, Messner H. Cholelithiasis in a newborn following treatment with the somatostatin analogue octreotide. Eur J Pediatr.2000 Jul;159(7):550.
Thornton PS, Alter CA, Katz LE, Baker L, Stanley CA. Short- and long-term use of octreotide in the treatment of congenital hyperinsulinism. J Pediatr.1993 Oct;123(4):637–43.
Arevalo RP, Bullabh P, Krauss AN, Auld PA, Spigland N. Octreotide-induced hypoxemia and pulmonary hypertension in premature neonates. J Pediatr Surg.2003 Feb;38(2):251–3.
Mordel A, Sivilotti MLA, Old AC, Ferm RP. Octreotide for pediatric sulfonylurea poisoning [abstract]. J Toxicol Clin Toxicol1998; 36: 437.
Kent DA, Main BA, Friesen MS. Use of octreotide in sulfonylurea poisoning in a child [abstract]. J Toxicol Clin Toxicol1993; 41: 669.
Calello DP, Osterhoudt KC, Henretig FM, Perrone J. Octreotide for pediatric sulfonylurea overdose: Review of 5 cases [abstract]. Clin Toxicol2005; 43: 671.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Calello, D.P., Kelly, A. & Osterhoudt, K.C. Case files of the medical toxicology fellowship training program at the children’s hospital of Philadelphia: A pediatric exploratory sulfonylurea ingestion. J. Med. Toxicol. 2, 19–24 (2006). https://doi.org/10.1007/BF03161009
Issue Date:
DOI: https://doi.org/10.1007/BF03161009